MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Skin Tau Quantification as a Novel Biomarker in Huntington’s Disease

    I. Ruiz Barrio, A. Vazquez Oliver, A. Puig Davi, E. Rivas Asensio, J. Perez Perez, C. Fernandez Vizuete, A. Horta Barba, G. Olmedo Saura, N. Salvat Rovira, E. Vacchi, G. Melli, J. Pagonabarraga Mora, S. Martinez Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore skin tau quantification as a potential biomarker for disease severity, motor and cognitive function in Huntington's disease Background: Beyond the aggregation of…
  • 2024 International Congress

    Predicting Clinical Status of Patients with Huntington’s Disease from Raw Speech Samples, a Lightweight Machine Learning Approach

    C. Le Moine, R. Massart, A-C. Bachoud-Lévi (Paris, France)

    Objective: We propose a machine learning-based method for inferring the clinical status of patients with Huntington’s Disease (HD) from raw voice recordings. Background: Assessing HD…
  • 2024 International Congress

    Closed-Loop Spinal Cord Stimulation: A Case Report on a Novel Therapeutic Approach for Post-Hypoxic Myoclonus

    A. Patel, L. Venkatesan (Trevose, USA)

    Objective: To present a case-study on use of closed-loop spinal cord stimulation (CL-SCS) for treating post-hypoxic myoclonus. Background: Post-hypoxic myoclonus is severely disabling and can…
  • 2024 International Congress

    Handwriting Features in Patients with Isolated REM Sleep Behaviour Disorder

    R. Torricelli, J. Kenny, E. Bache, L. Pérez-Carbonell, B. Huxford, H. Chohan, G. Leschziner, A. Lees, A. Schrag, A. Noyce, C. Simonet (London, United Kingdom)

    Objective: To assess iRBD patients’ handwriting features and develop a rating scale capable of detecting early hallmarks of disease. Background: Handwriting changes, such as micrographia,…
  • 2024 International Congress

    Spastic paraparesis and paroxysmal dystonia associated with a novel mutation in ATP1A3 in a spanish family

    FJ. Azcárate-Díaz, J. Herreros-Rodríguez, L. Llorente-Ayuso, S. Manzano, C. González González, P. Rábano-Suárez, T. Talaván, A. Esquivel (Madrid, Spain)

    Objective: To describe a new phenotype related to a novel mutation in ATP1A3 in two women from the same family Background: Mutations in ATP1A3 have…
  • 2024 International Congress

    Social phobia, anxiety and depression in patients with essential tremor

    S. Shtaimets, а. Shtraub, N. Zhukova, YU. Lalov, L. Tkachenko, I. Zhukova, A. Agasheva, D. Novotnyy (Omsk, Russian Federation)

    Objective: ET is the most diagnosed movement disorder, the frequency of which increases as a person ages. Background: To examine the incidence of social phobia,…
  • 2024 International Congress

    Age of Onset and Choice of First-line Therapy in Essential Tremor Patients

    F. Jamal, G. Jackson, A. Sarwar, P. Mandava (Houston, USA)

    Objective: The purpose of this study is to examine the effect of age of onset on the selection of initial medication for symptomatic management of…
  • 2024 International Congress

    MRgFUS thalamotomy for essential tremor: Lesion location and clinical outcomes

    M. Rodriguez-Oroz, AA. Arcadi, LGQ. Gonzalez Quarante, IA. Aviles-Olmos, AMB. Bastidas, AJH. Jimenez Huete, AG. Gorospe, JG. Guridi (Pamplona, Spain)

    Objective: To examine the clinical outcomes and their relationship with patients’ baseline demographic and clinical features and lesion characteristics at 6-month follow-up in ET patients.…
  • 2024 International Congress

    Expanding the Neurogenetic Spectrum: A Case of DEPDC5 Mutation Presenting with Unilateral Tremor and Cognitive Decline

    B. Center, Z. Cheng (Maywood, USA)

    Objective: Here, we report a novel presentation of DEPDC5-related disorders in a 41-year-old patient with unilateral tremors and delayed cognitive decline. Background: DEPDC5 mutations are…
  • 2024 International Congress

    Intermediate Expansion of MARCHF6 causes FAME3 without Epilepsy

    C. Del Gamba, E. Bieth, S. Kaya, E. Leitão, K. Astudillo, S. Frucht, C. Depienne, G. Riboldi (New York City, USA)

    Objective: To describe the first case of Familial adult myoclonic epilepsy 3 (FAME3) due to intermediate intronic expansion of MARCHF6. Background: FAME is an autosomal…
  • « Previous Page
  • 1
  • …
  • 129
  • 130
  • 131
  • 132
  • 133
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley